Web13. dec 2024. · Latest ONCT News. 03/27/23 9:00 AM Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4) 03/09/23 4:01 PM Oncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2024 Financial Results; Web12. apr 2024. · This is a lower news sentiment than the 0.41 average news sentiment score of Medical companies. News Coverage This Week MarketBeat has tracked 23 news …
Oncternal Therapeutics Participating in Oppenheimer & Co.’s …
WebNews. Press Releases. Research Reports. SEC Filings. ... ONCT) Q4 2024 Earnings Call Transcript March 9, 2024 Operator: Greetings and welcome to the Oncternal … Web06. apr 2024. · Get Oncternal Therapeutics Inc (ONCT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. tsco th 5318 wireless headset
Meteorologist Matt Scott - Facebook
Web23 hours ago · SAN DIEGO, April 13, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that two key industry opinion leaders and management will participate in Oppenheimer & Co.’s Virtual Fireside Chat: … WebONCT Price $0.28 Fair Value Price N/A Market Cap $16.15M 52 Week Low $0.27 52 Week High $1.87 P/E -0.33x P/B 0.26x P/S 35.3x PEG N/A Dividend Yield N/A Revenue $1.49M Earnings -$44.17M Gross Margin 100% Operating Margin -2,964.43% Profit Margin -2,964.4% Debt to Equity 0.13 Operating Cash Flow -$37M Beta 0.95 Next Earnings May … Web29. mar 2024. · ONCT Stock Overview. About the company. Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company’s clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine … phillywomenleaders.org